Original Biomedicals Co Ltd(TW:6483)
NT$14.80-0.25 (-1.66%)
TW:6483
Original Biomedicals Co Ltd financials statements
NT$14.80
At close:-0.25 (-1.66%)
Original Biomedicals Co Ltd (6483) Income Statement
Original Biomedicals Co Ltd Income Statement
Last quarter (Q2 2026), Original Biomedicals Co Ltd's total revenue was NT$0.00. In Q2, Original Biomedicals Co Ltd's net income was NT$-48.33M. See Original Biomedicals Co Ltd’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 381.00K | NT$ 0.00 | NT$ 43.00K | NT$ 107.00K | NT$ 0.00 | |
| NT$ 306.00K | NT$ -8.40M | NT$ 35.00K | NT$ 95.00K | NT$ -8.61M | |
| NT$ 104.90M | NT$ 69.93M | NT$ 59.30M | NT$ 40.27M | NT$ 24.05M | |
| Depreciation and Amortization | NT$ 8.83M | NT$ 8.40M | NT$ 8.74M | NT$ 7.94M | NT$ 8.61M |
| NT$ -92.09M | NT$ -65.73M | NT$ -49.83M | NT$ -31.20M | NT$ -23.88M | |
| NT$ -104.60M | NT$ -78.33M | NT$ -59.26M | NT$ -40.18M | NT$ -32.66M | |
| NT$ 3.09M | NT$ 3.33M | NT$ -399.00K | NT$ -101.00K | NT$ -1.21M | |
| NT$ -101.51M | NT$ -75.00M | NT$ -59.66M | NT$ -40.28M | NT$ -33.88M | |
| NT$ -101.51M | NT$ -75.00M | NT$ -59.66M | NT$ -40.28M | NT$ -33.88M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -1.54 | NT$ -1.14 | NT$ -1.21 | NT$ -0.86 | NT$ -0.81 |
| Diluted EPS | NT$ -1.53 | NT$ -1.14 | NT$ -1.21 | NT$ -0.86 | NT$ -0.81 |
| Weighted Average Shares Outstanding | 66.11M | 65.96M | 49.31M | 46.83M | 41.62M |
| Weighted Average Shares Outstanding (Diluted) | 66.31M | 65.96M | 49.34M | 46.83M | 41.62M |
Currency in TWD

